Search by property
From GxPlex
This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.
List of results
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 16 +
- Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - Ende +
- Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2 +
- Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.7.5 +
- Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 3.2 +
- Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 3.3 +
- Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1123-20 +
- Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1123-20-1 +
- Reference:FRA SI RIPH 2G - Website 16-May-2025 - +
- Reference:FRA AEC-DM-DMDIV DOC006 v04 AAP RDM Partie II Modalités pratiques 16-May-2025 - +
- Reference:FRA AEC DOC010 V.04 01-Jun-2018 - +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 - 12 +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 (1) +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 14 +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (1) - (6) +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (7) - (10) +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 17 +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 18 +
- Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20 +
- Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 16 (1) - (3) +
- Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. +
- Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 1. - 4. +
- Reference:GBR NIHR - National Institute for Health and Care Research 28-Jan-2025 - +
- Reference:GBR IRAS - Integrated Research Application System 28-Jan-2025 IRAS +
- Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.102 (m) +
- Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.103 +
- Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.104 +
- Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.105 +
- Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.109 +
- Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.111 - §56.112 +
- Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.124 +
- Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.40 (b) +
